Grand Round pubblico
[search 0]
Altro

Scarica l'app!

show episodes
 
Thalamus Grand Rounds is a podcast created by and for current and former residents, program coordinators and directors to spotlight and empower GME leaders to innovate the residency and fellowship recruitment processes. You’ll hear insightful discussions about all things GME including virtual interview best practices, managing expectations of applicants and faculty, promoting DEI initiatives and holistic review, data and analytics to drive recruitment and much more.
 
Grand Rounds, a staple of American medical education for more than 100 years, spans every field of clinical practice. It is a master class on the art and science of medicine, delivered by renowned clinicians in academic settings nationwide. Yet in today's practice, where time is an all-too precious commodity, regular attendance at Grand Rounds sessions has become increasingly difficult. In response to this challenge, ReachMD brings the lecture hall to you, with these outstanding talks from t ...
 
As part of our mission to end cardiovascular disease, The Minneapolis Heart Institute Foundation offers weekly cardiology Grand Rounds to stay up-to-date on the latest developments in cardiology. These weekly meetings feature topics from the following cardiac specialty areas: congestive heart failure, electrophysiology, cardiac imaging, interventional cardiology, heart disease prevention, cardiac surgery, vascular/endovascular and miscellaneous.
 
Lectures and discussions to help meet the continuing education needs of physicians and other healthcare professionals involved in neonatal, cardiology, pediatric, obstetric and maternal-fetal medicine. These podcasts are presented through Pediatrix University by the The Center for Research, Education and Quality. The Grand Rounds forum provides topics in neonatal-perinatal medicine. Educational activities offer a combined slide and audio presentation, as well as mp3, mp4, and a non-audio opt ...
 
Loading …
show series
 
Kyle A. Hess, Pharm.D., recognizes the clinical presentation of beta-lactam induced neurotoxicity, identifies risk factors associated with developing beta-lactam induced neurotoxicity and describes the relationship between drug levels of beta-lactams and development of neurotoxicity. For more pharmacy content, follow Mayo Clinic Pharmacy Residency …
 
Nikitha Yagnala, Pharm.D., defines iatrogenic withdrawal syndrome in critically ill patients, identifies risk factors for iatrogenic withdrawal syndrome and reviews the current evidence for management of iatrogenic withdrawal syndrome. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Sc…
 
Jo Ann Leal, Pharm.D., describes the epidemiology of stress ulcers and stress ulcer prophylaxis in select critically ill patients, evaluates the literature that examines the incidence of gastrointestinal bleeding in patients receiving corticosteroids and the outcomes of stress ulcer prophylaxis in patients on dual antiplatelet therapy and analyzes …
 
Kaylee A. Clark, Pharm.D., reviews the types of hypersensitivity reactions, discusses the pathophysiology and common features of different hypersensitivity reactions to chemotherapeutic agents and describes appropriate prevention and management strategies for hypersensitivity reactions. For more pharmacy content, follow Mayo Clinic Pharmacy Residen…
 
Molly A. McCord, Pharm.D., describes the mechanism of action of belatacept, recognizes the role of belatacept in immunosuppression therapy and identifies a patient in whom belatacept therapy may be considered. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_…
 
In episode three, we spoke with Starla Pathak, Manager of Educational Programs, Department of Orthopedics, Tufts Medical Center, about the importance of properly preparing your ​recruitment team for interview season, and doing your best to help applicants accurately anticipate what the interview process will be like.…
 
Marissa Z. Powell, Pharm.D. (@MarissaP_PharmD), reviews the pathophysiology of nausea and vomiting, describes antiemetic agents and considerations for their use and discusses concern for QT prolongation with use of antiemetics. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, P…
 
Michaela E. Wermers, Pharm.D., describes the epidemiology and pathogenicity of coagulase-negative Staphylococcus (CoNS) species, outlines an evidence-based approach to determine the clinical significance of CoNS isolates and identifies empiric and definitive treatment regimens for pathogenic CoNS. For more pharmacy content, follow Mayo Clinic Pharm…
 
Sydney E. Schultz, PharmD identifies signs, symptoms, and diagnostic criteria for multiple myeloma, reviews pharmacology of medications used as primary treatment for multiple myeloma and discusses recent literature regarding four-drug regimens. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garr…
 
Cassandra J. Schmitt, PharmD (@cjschmitt2) Identifies the risk stratifications for submassive pulmonary embolism, discusses efficacy and safety outcomes for thrombolytics in submassive pulmonary embolism and selects the ideal candidate to receive thrombolysis for a submassive pulmonary embolism. For more pharmacy content, follow Mayo Clinic Pharmac…
 
Hannah M. Brokmeier, PharmD (@hannahbrokmeier) compares and contrasts the pharmacokinetic and pharmacodynamic properties of heparin and bivalirudin in extracorporeal support, identifies clinical scenarios that favor either heparin or bivalirudin for anticoagulation in ECMO and selects a preferred agent for ECMO when either heparin or bivalirudin ar…
 
In episode two, we spoke with with Dawn DeSantis, Division Administrator, Graduate Medical Education, Department of Pediatrics at the University of Florida — Jacksonville. Listen for an insightful and productive conversation about big picture qualities to look for in candidates, the importance of personal statements, how programs can implement holi…
 
Danielle M. Hess, PharmD (@dhess_09) describes the pathophysiology of opioid-induced constipation (OIC), evaluates literature depicting the safety and efficacy of peripherally-acting mu-opioid receptor antagonists (PAMORAs) for the treatment of OIC and applies the clinical pearls of PAMORAs to patient care. For more pharmacy content, follow Mayo Cl…
 
Audrey J. Umbreit, PharmD, BCACP describes alcohol use disorder (AUD) as a chronic disease, identifies evidence-based medications for treatment of AUD and selects a medication based on individual patient factors to treat AUD. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pha…
 
Brandi N. Smith, PharmD, BCPPS defines necrotizing enterocolitis and late-onset sepsis in the premature neonate and proposed mechanisms of prevention with probiotic use, reviews literature supporting the use of probiotics in premature neonates and recognizes ongoing questions in using probiotics in premature neonates. For more pharmacy content, fol…
 
Kaitlyn J. Bailey, PharmD (@pharmgirl1821) describes the mechanisms of action of select CDK46, PI3K, and PARP inhibitors, reviews the outcomes data related to CDK46, PI3K, and PARP inhibitors for treatment of metastatic breast cancer and discusses toxicity management for CDK46, PI3K, and PARP inhibitors. For more pharmacy content, follow Mayo Clini…
 
Mai Uyen Alissa Le, PharmD describes the utility and importance of anticoagulation in ECMO, identifies clinical factors to consider with the use of bivalirudin anticoagulation in ECMO and discusses literature evaluating the use of bivalirudin and its comparison to heparin for anticoagulation in pediatric patients supported on ECMO. For more pharmac…
 
Joseph C. Osborne III, PharmD (@JOzempic) describes the current framework of deprescribing, reviews literature pertinent to deprescribing in the inpatient setting and identifies facilitators, barriers, and future directions for deprescribing. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garret…
 
Natalie A. Haddad, PharmD (@NatalieHaddadRx) describes the epidemiology of multisystem inflammatory syndrome in children (MIS-C), outlines key similarities and differences between MIS-C and other comparable pediatric conditions and discusses current potential therapeutic options for the treatment of MIS-C. For more pharmacy content, follow Mayo Cli…
 
Kyle S. Wamsley, PharmD (@KyleWamsley1) describes the pathophysiology and complications associated with alcohol withdrawal syndrome (AWS), reviews treatment modalities and commonly utilized agents for AWS in the ICU setting and outlines appropriate phenobarbital dosing regiments based on current literature. For more pharmacy content, follow Mayo Cl…
 
Erin D. Wieruszewski, PharmD, BCCCP (@EDWieru) describes the goals of treatment for intracranial hemorrhage, discusses literature examining the use of desmopressin and tranexamic acid for intracranial hemorrhage and identifies appropriate patients to receive treatment with desmopressin or tranexamic acid. For more pharmacy content, follow Mayo Clin…
 
Danielle M. Hess, PharmD (@dhess_09) describes the role of nutrition in cirrhosis and deficiency patterns as it relates to disease severity, evaluates literature depicting the impact of vitamin A, vitamin D, and zinc deficiencies on complications associated with cirrhosis and discusses micronutrient supplementation and monitoring recommendations fo…
 
Hannah M. Brokmeier, PharmD (@hannahbrokmeier) reviews current accepted standards in sedation practices, compares pharmacologic properties of propofol and dexmedetomidine for light sedation and evaluates evidence for choice of optimal sedative agent in light sedation. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPh…
 
In our inaugural episode, we sat down with Carey McDonald, MBA, Residency Program Manager for the East Carolina University Department of OB/GYN, and Tim Burns, Program Administrator for the University of Vermont Medical Center OB/GYN Residency Program. We had a robust and frank discussion about creating an excellent virtual interview process, and n…
 
Cassandra J. Schmitt, PharmD (@cjschmitt2) identifies guideline recommendations for antiplatelet agents following percutaneous coronary intervention (PCI), reviews the literature examining the safety and efficacy of clopidogrel, ticagrelor, and prasugrel and discusses factors that influence the selection of a P2Y12 agent following PCI. For more pha…
 
Mary A. Gilmer, PharmD, MHA, BCPS reviews common causes and origins of drug shortages, describes the impacts and implications of drug shortages and discusses strategies and processes for drug shortage management. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garre…
 
Ashley Kate Ragan, PharmD defines actionable proton pump inhibitor (PPI) drug-gene associations, discusses current pharmacogenomic PPI guidelines, including the 2018 Dutch Pharmacogenomic Working Group (DPWG) and 2020 Clinical Pharmacogenetic Implementation Consortium (CPIC) and reviews primary literature depicting CYP2C19 guided PPI dosing. For mo…
 
Alicia E. Mattson, PharmD, BCPS, BCCCP (@AM_EM_PharmD) describes the goals of pharmacotherapy in RSI, discusses literature surrounding medication choice and dose for RSI and selects an appropriate induction and paralytic medication for a patient requiring RSI. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes o…
 
Nathan T. Smith, PharmD, BCPS recalls the clinical presentation of gender incongruence, identifies current treatment options for transgender men and women and describes potential cardiovascular risks associated with gender-affirming hormone therapy. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host,…
 
Mikaela Hofer, Pharm.D., BSPS, BCCCP (@mikaelamhofer) identifies limitations of current vasopressor agents for the treatment of septic shock, reviews novel vasopressor therapies with a current or potential role in the management of septic shock and describes advancements in the development of biomarkers and pharmacogenomics for the monitoring and i…
 
Allison Golbach, PharmD, BCPS (@AllisonGPharmD) describes epidemiology, pathophysiology, and prognosis of acute myeloid leukemia (AML), reviews literature supporting induction regimens for patients with AML without targetable mutations and discusses how to select between AML induction regimens based on patient-specific factors. For more pharmacy co…
 
Nicole Hlavacek, PharmD (@HlavacekPharmD) recognizes the proposed mechanism of magnesium in different pathologies, recalls dosing and administration rates for magnesium and describes effectiveness of magnesium. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett…
 
Hannah Poppen, PharmD (@PoppenPharmD) reviews guideline recommendations for management of blood cholesterol, describes the risks and benefits associated with adjunct non-statin therapy and identifies patient-specific characteristics in which PCSK9 inhibitor therapy should be considered. For more pharmacy content, follow Mayo Clinic Pharmacy Residen…
 
Nicholas Vollmer, PharmD (@VollmerNick) describes the mechanism through which thromboelastography works and how it differs from current assessments of coagulation, identifies patient scenarios where thromboelastography may be of benefit compared to standard of care and discovers barriers of widespread use of thromboelastography. For more pharmacy c…
 
Yen Tran, PharmD, MBA (@YenTranlt) illustrates the consequences of antibody mediated rejection (AMR) on solid organ transplant recipients, develops a management strategy for AMR and outlines approaches to AMR management. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D.…
 
Mikhaila Rice, PharmD, BCPS (@MikhailaPharmD) reviews pathophysiology of gastrointestinal stromal tumors, describes the pharmacology of medications used to treat gastrointestinal stromal tumors and discusses the place in therapy of new treatment options, including ripretinib and avapritinib. For more pharmacy content, follow Mayo Clinic Pharmacy Re…
 
Laurel Lake, PharmD (@laurel_pharmd) outlines the guideline recommendations for duration of antiplatelet therapy in acute coronary syndrome in patients using anticoagulation for atrial fibrillation, reviews recent literature examining antiplatelet therapy in patients with atrial fibrillation and stable coronary artery disease and discusses the bala…
 
Dylan Kosaski, PharmD (@Dylan_Kosaski) identifies the purpose of 340B and the impact on health care costs, evaluates the role of 340B contract pharmacies and reviews challenges facing the 340B program and potential consequences. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, …
 
Kellyn Engstrom, PharmD, MPH (@KellynEPharmD) lists three differences between COVID-19 immunization efforts and previous mass immunization strategies, describes challenges in complying with vaccine delivery, storage, and administration processes required by FDA emergency use authorization and summarizes the current state and future directions of CO…
 
Jennifer Adema, PharmD, MBA (@JAdemaPharmD) describes remdesivir’s mechanism of action against SARS-CoV-2, identifies optimal adult patient populations for remdesivir and outlines future directions for remdesivir in COVID-19 treatment. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Sc…
 
Andrew Webb, Pharm.D. (@AJWPharm) describes the pharmacokinetic alterations of critical illness and the implications for beta-lactam optimization, recognizes the potential role of beta-lactam therapeutic monitoring in predicting drug effectiveness, and identifies the potential role of beta-lactam therapeutic monitoring in recognizing drug toxicity.…
 
Hannah Brokmeier, Pharm.D. (@hannahbrokmeier) discusses the role of MRAs in patients with ESRD, reviews the literature concerning risks and benefits of MRAs in patients with ESRD, and outlines a potential MRA treatment regimen for a patient with dialysis-dependent ESRD. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @Mayo…
 
Kyle Wamsley, Pharm.D. (@KyleWamsley1) discusses current literature surrounding the use of oral antimicrobials in the treatment of infective endocarditis (IE), identifies specific patient populations in whom it may be appropriate to consider oral therapy for the treatment of IE, and outlines oral antimicrobial regimens which may be most appropriate…
 
Ashley Otto, Pharm.D., BCPS describes the pathophysiology of non-pulmonary clinical manifestations in cystic fibrosis (CF), reviews guideline recommendations and primary literature to manage non-pulmonary CF complications, and selects appropriate treatment options for patients with non-pulmonary CF complications. For more pharmacy content, follow M…
 
Cassandra Schmitt, Pharm.D. (@cjschmitt2) describes the differences between thrombolytic agents used for the treatment of ischemic stroke, discusses the literature examining the efficacy and safety outcomes of tenecteplase, and identifies the role of tenecteplase in ischemic stroke thrombolysis. For more pharmacy content, follow Mayo Clinic Pharmac…
 
Shannon Piche, Pharm.D., BCPS describes the incidence and clinical manifestation of PICS, reviews literature examining the long term implications of critical illness, and discusses current strategies to address care gaps related to PICS symptom recognition and management. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @Ma…
 
Allison Golbach, Pharm.D., BCPS (@AllisonGPharmD) reviews the definition, background, and measurement of financial toxicity, discusses the impact of financial toxicity on patients’ clinical outcomes, and identifies methods to help patients make informed decisions about their oncology care. For more pharmacy content, follow Mayo Clinic Pharmacy Resi…
 
Kellyn Engstrom, Pharm.D., MPH (@KellynEPharmD) reports on current guideline recommendations and gaps in evidence for the treatment of status epilepticus, interprets recent evidence regarding conventional antiepileptic utilization in status epilepticus, and lists three considerations in applying new evidence for status epilepticus treatment into cl…
 
Mikhaila Rice, Pharm.D., BCPS (@MikhailaPharmD) reviews chronic lymphocytic leukemia diagnosis and historical treatment options, describes the pharmacology of Bruton tyrosine kinase inhibitors and venetoclax, and discusses the use of targeted agents as first line therapy for chronic lymphocytic leukemia. For more pharmacy content, follow Mayo Clini…
 
Madison Fazio, Pharm.D. (@madison_fazio) discusses new guideline recommendations for the management of gout, reviews the literature contributing to the new gout recommendations, and recognizes patients that would benefit from newer gout therapies based on guideline recommendations. For more pharmacy content, follow Mayo Clinic Pharmacy Residency Pr…
 
Loading …

Guida rapida

Google login Twitter login Classic login